Welcome to the UPF Digital Repository

Burden of neurological diseases in the US revealed by web searches

Show simple item record

dc.contributor.author Baeza Yates, Ricardo
dc.contributor.author Mohan Sangal, Puneet
dc.contributor.author Villoslada, Pablo
dc.date.accessioned 2021-07-07T07:23:42Z
dc.date.available 2021-07-07T07:23:42Z
dc.date.issued 2017
dc.identifier.citation Baeza Yates R, Mohan Sangal P, Villoslada P. Burden of neurological diseases in the US revealed by web searches. PLoS ONE. 2017;12(5):e0178019. DOI: 10.1371/journal.pone.0178019
dc.identifier.issn 1932-6203
dc.identifier.uri http://hdl.handle.net/10230/48104
dc.description.abstract Background: Analyzing the disease-related web searches of Internet users provides insight into the interests of the general population as well as the healthcare industry, which can be used to shape health care policies. Methods: We analyzed the searches related to neurological diseases and drugs used in neurology using the most popular search engines in the US, Google and Bing/Yahoo. Results: We found that the most frequently searched diseases were common diseases such as dementia or Attention Deficit/Hyperactivity Disorder (ADHD), as well as medium frequency diseases with high social impact such as Parkinson’s disease, MS and ALS. The most frequently searched CNS drugs were generic drugs used for pain, followed by sleep disorders, dementia, ADHD, stroke and Parkinson’s disease. Regarding the interests of the healthcare industry, ADHD, Alzheimer’s disease, MS, ALS, meningitis, and hypersomnia received the higher advertising bids for neurological diseases, while painkillers and drugs for neuropathic pain, drugs for dementia or insomnia, and triptans had the highest advertising bidding prices. Conclusions: Web searches reflect the interest of people and the healthcare industry, and are based either on the frequency or social impact of the disease.
dc.description.sponsorship This study was funded by CERCA Program / Generalitat de Catalunya to PV. Funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Amazon Inc., a commercial company provided support in the form of salaries for author PS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Public Library of Science (PLoS)
dc.relation.ispartof PLoS ONE. 2017;12(5):e0178019
dc.rights © 2017 Baeza-Yates et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. https://creativecommons.org/licenses/by/4.0/
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.title Burden of neurological diseases in the US revealed by web searches
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1371/journal.pone.0178019
dc.subject.keyword Neurological drug therapy
dc.subject.keyword Advertising
dc.subject.keyword Information retrieval
dc.subject.keyword ADHD
dc.subject.keyword Central nervous system
dc.subject.keyword Alzheimer's disease
dc.subject.keyword Health care sector
dc.subject.keyword Parkinson disease
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking